Cencora, Inc. (cor)
COR — Company Overview
Investors tracking COR follow a Medical Distribution name listed on NYQ within Healthcare.
| Ticker | COR |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Exchange | NYQ |
| Market cap | $59.59B |
| Last price | $312.28 |
| Size category | Large Cap |
COR — Business Description
The business profile of Cencora, Inc. (COR) reflects its role in Medical Distribution. Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutiona…
Official website: https://www.cencora.com.
COR — Investment Thesis
Cencora, Inc. (COR) attracts investors weighing Medical Distribution fundamentals against current market pricing.
- Revenue is expanding at roughly 5.1% year-over-year (public data).
- Trailing P/E of 23.36× sits in a moderate band relative to high-growth peers.
- Forward P/E (15.77×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 0.8% adds an income component to total return.
- Equity market capitalization is approximately $59.59B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
COR — Financial Health
COR financial profile reflects operating efficiency and capital structure using available market fundamentals.
Profit margin near 0.8% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $2.04B supports balance-sheet flexibility. Debt-to-equity of 446.52 warrants monitoring in a higher-rate environment.
| Trailing P/E | 23.36× |
| Forward P/E | 15.77× |
| Price / Sales | 0.18× |
| Price / Book | 19.53× |
| Gross margin | 4.0% |
| Operating margin | 1.4% |
| Profit margin | 0.8% |
| Return on equity | 96.9% |
| Debt / Equity | 446.52 |
| Free cash flow | $2.04B |
COR — Growth Outlook
Growth outlook for Cencora, Inc. (COR) depends on demand trends in Medical Distribution and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 5.1% suggests steady but measured expansion.
- Earnings growth of 11.9% year-over-year supports improving profitability.
- Price is 17.3% below the 52-week high.
- Shares trade 27.6% above the 52-week low — limited rebound so far.
COR — Competitive Position
Cencora, Inc. (COR) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Distribution.
- Market capitalization of $59.59B places COR among large-cap peers.
- Gross margin of 4.0% should be benchmarked against direct competitors.
COR — Strengths
Strengths for Cencora, Inc. (COR) inferred from public financial metrics:
- Revenue growth of 5.1% year-over-year.
- Earnings growth of 11.9% year-over-year.
- Return on equity near 96.9% — efficient use of shareholder capital.
- Positive free cash flow ($2.04B).
- Large Cap scale ($59.59B) may provide distribution and funding advantages.
COR — Weaknesses
Weaknesses and pressure points for Cencora, Inc. (COR) based on available data:
- Thin profit margin (0.8%).
- Elevated debt-to-equity (446.52).
COR — Opportunities
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
COR — Risks
- Leverage (debt/equity 446.52) raises sensitivity to credit conditions.
- Thin margins leave less room for operational missteps.
COR — Summary
Cencora, Inc. (COR) is a large-cap Healthcare company focused on Medical Distribution, listed on NYQ. Last price $312.28 with market cap $59.59B. Trailing P/E 23.36×. Revenue grew 5.1% year-over-year per public data. Notable strengths include revenue growth of 5.1% year-over-year. Key watch items include thin profit margin (0.8%). Review free estimates and earnings pages for COR; upgrade for institutional ownership and live headlines.
Start Free — open COR in Vest Terminal
Access live data, filings, ownership, and analysis for Cencora, Inc..
Cencora, Inc. FAQ
What does Cencora, Inc. (COR) do?
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipmen…
What is COR's P/E ratio?
Cencora, Inc. has a trailing P/E of 23.36× based on publicly available market data.
Does COR pay a dividend?
Indicated dividend yield: 0.8%. Confirm ex-dates and payout history in Vest Terminal.
What sector is COR in?
Cencora, Inc. is classified in Healthcare (Medical Distribution) on NYQ.
What is COR's market capitalization?
Approximate market cap: $59.59B.
What are the main risks for COR?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of COR?
Potential positives include revenue growth of 5.1% year-over-year, earnings growth of 11.9% year-over-year.
Where can I get analyst estimates for COR?
Public analyst price targets and consensus for Cencora, Inc. are on the free /stocks/cor/estimates page. Deeper estimate history and models are available in Vest Terminal.